Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D.
Lancet 352(9127): 541
1998
ISSN/ISBN: 0140-6736 PMID: 9716060 Document Number: 495521
Document emailed within 1 workday
Related Documents
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Morris, A.D.; Morris, R.D.; Wilson, J.F.; White, J.; Steinberg, S.; Okunieff, P.; Arriagada, R.; Lê, M.G.; Blichert-Toft, M.; van Dongen, J.A. 1997: Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival Cancer Journal from Scientific American 3(1): 6-12
Zajdela, A.; De Maublanc, M.A.; Pilleron, J.P. 1981: Reliability of cytology in management of lesions of the breast. 25 years of the experience at Institut Curie, Paris Chirurgie; memoires de l'Academie de chirurgie 107(3): 193-198
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Axelsson, C.K.; Andersen, J.A.; Andersen, K.W.; Blichert-Toft, M.; Dombernowsky, P.; Hansen, M.; Krag, C.; Mouridsen, H.T.; Overgaard, M.; Rasmussen, B.B. 1991: Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group) Ugeskrift for Laeger 153(33): 2276-2279
Roach, M.; Cirrincione, C.; Budman, D.; Hayes, D.; Berry, D.; Younger, J.; Hart, R.; Henderson, I.C. 1997: Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541 Cancer Journal from Scientific American 3(2): 107-112
Song, C.-g.; Hu, Z.; Yuan, W.-t.; Di, G.-h.; Shen, Z.-z.; Huang, W.; Shao, Z.-m. 2005: Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai Zhonghua Yi Xue Za Zhi 85(43): 3030-3034
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11
Craig, T.J.; Comstock, G.W.; Geiser, P.B. 1974: Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls Journal of the National Cancer Institute 53(6): 1577-1581
Zal'tsman, I.N.; Kolganova, I.P. 1978: Importance of roentgenological detection of early forms of breast cancer, during mass screening, for patients' survival Vestnik Rentgenologii i Radiologii 4: 75-82
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Fortunato, L.; Drago, S.; Vitelli, C.E.; Santoni, M.; Gucciardo, G.; Cabassi, A.; Farina, M.; La Pinta, M.; Remedi, M.; Pagano, G.; Silipod, T.; Terribile, D.; Stagnitto, D.; Grassi, G.B. 2006: Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group Chirurgia Italiana 58(6): 689-696
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Axelsson, C.K.; Mouridsen, H.T.; Zedeler, K. 1992: Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG) European Journal of Cancer 28a(8-9): 1415-1418